AN2 Therapeutics, Inc. Common Stock —— 季度财务报表 (NASDAQ:ANTX) | MetaTrader

展开完整图表

Financials

概览声明统计股息 Documents

每季度年度

Market Capitalization 206.79 M
Employee 21
Founded 2017
CEO N/A
Website www.an2therapeutics.com
Headquarter Delaware, United States
FIGI BBG00QYLYBK4
Industry 生物技术

总收入

净利润

每股基本收益（基本 EPS）

总债务

自由现金流

现金及现金等价物

Related tickers

	#	姓名	价格	24小时 %	7天 %	一个月 %	一年 %	市值	最近7天
	3580	PLX Protalix BioTherapeutics, Inc. Common Stock	2.60 USD	+0.78%	+8.33%	+9.24%	-10.96%	209.49 M USD
	3585	BCYC Bicycle Therapeutics plc - American Depositary Shares	4.10 USD	-0.73%	-6.61%	+7.61%	-42.98%	207.28 M USD
	3591	CUE Cue Biopharma, Inc. - Common Stock	28.44 USD	+11.44%	+6.80%	+5.33%	+3455.00%	206.60 M USD
	3604	ORMP Oramed Pharmaceuticals Inc. - Common Stock	4.85 USD	-3.39%	-8.14%	+18.00%	+123.50%	201.75 M USD